IRCT20211210053343N1 IRCT 2021-12-29 Iran University of Medical Sciences Comparison of the effect of minoxidil and spironolactone with minoxidil and finasteride in the treatment of Androgenic Alopecia Comparative study of the combined effect of topical minoxidil and oral spironolactone with the combined effect of topical minoxidil and oral finasteride on female pattern and male pattern hair loss in women referred to Rasool Akram and Firoozgar hospitals in 1400-1401 2022-01-05 anticipated 60 Complete https://irct.ir/trial/60615 interventional Randomization: Randomized, Blinding: Not blinded, Placebo: Not used, Assignment: Parallel, Purpose: Treatment, Randomization description: for each group of the disease, patients with female pattern hair loss and patients with male pattern hair loss, After being selected by available method, patients are divided into two groups by simple randomization, so that among 30 sealed bags, one bag will be randomly selected for each patient. Each bag contains the letter a or b: a for the group receiving Minoxidil and Spironolactone and b for the group receiving Minoxidil and Finasteride. 3 Androgenic Alopecia. Intervention 1: Intervention group 1: Patients in the first group use Minoxidil solution 2% once a day and Spironolactone (100 mg daily in two doses) for 4 months. Intervention 2: Intervention group 2: Patients in the second group use Minoxidil solution 2% once a day and finasteride (5 mg per day) for 4 months. Undecided - It is not yet known if there will be a plan to make this available Justification or reason for indecision in sharing IPD is It is not yet known if there will be a plan to make this available.